Melanocortin Research
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide and melanocortin-receptor agonist derived from the peptide hormone α-MSH. In research it is studied as a tool compound at the melanocortin receptors (notably MC4R), which places it in in-vitro work on melanocortin signalling.
This page serves European research buyers sourcing PT-141 for laboratory studies. Supplied as a 10 mg lyophilised vial strictly for research — not for human or veterinary use — to a ≥99% purity target, lot-tracked, and shipped tracked from inside the EU. Independent per-batch Certificate-of-Analysis testing is our published testing standard.
Looking for something else? Browse all research peptides → · reconstitution calculator
Research-use answers for buyers sourcing PT-141 in the EU.
PowerfullyPeptides supplies PT-141 (bremelanotide) as a 10 mg lyophilised vial to research buyers across Europe, dispatched tracked from inside the EU (Ireland). Sold strictly for laboratory research use only.
In the laboratory, PT-141 is studied as a melanocortin-receptor agonist tool compound, chiefly in in-vitro work on melanocortin (MC4R) signalling. It is supplied strictly for research; we make no claims regarding use in humans or animals.
Material is specified to a ≥99% purity target and lot-tracked. Independent per-batch Certificate-of-Analysis testing is our published testing standard — see our COA page.
Occasional, useful email: new-batch and restock notices, the free reconstitution calculator and guides, plus FIRST10 for 10% off your first order. No daily blasts.
English
EUR €